CID 16131641

Isis 9034

Structural Information

Molecular Formula
C97H124N35O51P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=O)(OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)S)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)O
InChI
InChI=1S/C97H124N35O51P9S9/c1-38-20-126(95(144)120-83(38)135)64-10-41(134)52(166-64)24-156-184(147,193)176-43-12-65(123-7-4-61(98)111-92(123)141)167-53(43)25-158-188(151,197)179-46-15-69(128-22-40(3)85(137)122-97(128)146)170-56(46)28-161-191(154,200)182-49-18-72(131-36-109-76-81(131)115-90(103)118-87(76)139)174-60(49)32-164-192(155,201)183-50-19-73(132-37-110-77-82(132)116-91(104)119-88(77)140)173-59(50)31-163-187(150,196)178-45-14-67(125-9-6-63(100)113-94(125)143)168-54(45)26-159-189(152,198)180-47-16-70(129-34-107-74-78(101)105-33-106-79(74)129)171-57(47)29-162-186(149,195)177-44-13-66(124-8-5-62(99)112-93(124)142)169-55(44)27-160-190(153,199)181-48-17-71(130-35-108-75-80(130)114-89(102)117-86(75)138)172-58(48)30-157-185(148,194)175-42-11-68(165-51(42)23-133)127-21-39(2)84(136)121-96(127)145/h4-9,20-22,33-37,41-60,64-73,133-134H,10-19,23-32H2,1-3H3,(H,147,193)(H,148,194)(H,149,195)(H,150,196)(H,151,197)(H,152,198)(H,153,199)(H,154,200)(H,155,201)(H2,98,111,141)(H2,99,112,142)(H2,100,113,143)(H2,101,105,106)(H,120,135,144)(H,121,136,145)(H,122,137,146)(H3,102,114,117,138)(H3,103,115,118,139)(H3,104,116,119,140)
InChIKey
QSZMVQRZMJXYGF-UHFFFAOYSA-N
Compound name
1-[5-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[hydroxy-[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-sulfanylphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3161.331 Da
Monoisotopic Mass

-5.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3162.3383 294.5
[M+Na]+ 3184.3202 298.9
[M-H]- 3160.3237 295.5
[M+NH4]+ 3179.3648 296.3
[M+K]+ 3200.2942 296.6
[M+H-H2O]+ 3144.3283 295.0
[M+HCOO]- 3206.3292 296.4
[M+CH3COO]- 3220.3449 296.8
[M+Na-2H]- 3182.3057 300.2
[M]+ 3161.3305 298.6
[M]- 3161.3315 298.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.